PeptideStackers
Approved medicinePeptideaka Egrifta · GHRH analog

Tesamorelin

A GHRH analog that's actually FDA-approved — for a specific condition (HIV-associated belly-fat accumulation). That approval makes it a rare high-evidence peptide, and a useful yardstick for judging everything else.

ProofBDecent human data, some gaps.
Promise3/5
Risk2/5
Risk/Reward 78%

What people claim

Reduces visceral (deep abdominal) fat and supports body composition via the GH axis.

Human evidence

Real, approval-grade human trial data — for its approved use (reducing visceral adipose tissue in HIV-associated lipodystrophy). That's a genuine, regulator-reviewed evidence base, which almost nothing else in the grey-market peptide world has. Evidence for general 'wellness' fat loss in healthy people is much thinner.

Animal evidence

Preclinical GHRH-analog work supported its development; the human trial data is what earned approval.

Risk flags

  • Long-term effects unknown
  • Cardiovascular effects unclear
  • Injection & sterility risk

Regulatory status

US: FDA-approved (Egrifta) for HIV-associated lipodystrophy. Off-label / grey-market use for general fat loss is a different, unapproved context.

UK: Regulatory status differs from the US; not a general wellness-approved product. Check current MHRA status before relying on it.

What people report

Typical reported ranges — reporting, not a recommendation

Its approved use has a defined, prescribed regimen set by the label and a clinician — which is exactly the point: this one has a real, studied dose because it went through trials.

The approved dose applies to the approved condition under medical supervision. Copying it for general fat loss from a grey-market vial is off-label self-experimentation. We point to the existence of a real regimen; we don't restate numbers as guidance.

Everyone's an expert

Who says what

Gym Bros Say

"The 'legit' GH-axis one — it's actually approved. People use it to shave visceral fat."

Clinics Say

Can be prescribed for its approved indication; used off-label elsewhere for body composition.

Reddit Says

Respected as one of the few with real approval and trial data; discussion focuses on off-label fat-loss use and cost.

Big Pharma Says

A genuinely developed, approved medicine — the model of what 'evidence' actually looks like in this category.

Science Actually Says

Grade B. Approval-grade human evidence for its specific indication; weaker support for general-population 'wellness' fat loss.

PeptideStackers Says

Use it as your measuring stick. When a grey-market peptide claims miracles, ask why it never cleared the bar tesamorelin did. Approved-for-something ≠ approved-for-you, though.

Honesty section

What we still don't know

  • ?How well the approved-use benefits transfer to healthy people using it off-label.
  • ?Long-term effects of off-label use outside the studied population.
  • ?Whether grey-market 'tesamorelin' is even the real molecule at label strength.

Real questions people ask

FAQ

Is tesamorelin FDA-approved?
Yes — for HIV-associated lipodystrophy (reducing visceral fat), marketed as Egrifta. Using it for general fat loss in healthy people is off-label and less well-supported.
Is tesamorelin better than other GH peptides?
It has something almost none of them do: regulator-reviewed human trial data behind an approval. That makes its evidence base far stronger — for its specific approved use.

Before you do anything

Questions to ask a qualified professional

  • 01Does its approved indication actually match my situation?
  • 02What monitoring does the label call for?
  • 03If I'm using it off-label, do I understand that's outside what was studied?

Sources

Last reviewed: 2026-07-07